A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 29,447 shares of JAZZ stock, worth $3.22 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
29,447
Previous 25,264 16.56%
Holding current value
$3.22 Million
Previous $3.04 Million 3.29%
% of portfolio
0.17%
Previous 0.17%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$103.94 - $118.98 $434,781 - $497,693
4,183 Added 16.56%
29,447 $3.14 Million
Q1 2024

Apr 17, 2024

BUY
$115.19 - $132.77 $512,019 - $590,162
4,445 Added 21.35%
25,264 $3.04 Million
Q4 2023

Jan 10, 2024

BUY
$114.26 - $136.0 $616,318 - $733,584
5,394 Added 34.97%
20,819 $2.56 Million
Q3 2023

Oct 27, 2023

BUY
$122.0 - $145.31 $391,376 - $466,154
3,208 Added 26.26%
15,425 $2 Million
Q2 2023

Aug 09, 2023

BUY
$122.5 - $147.16 $359,537 - $431,914
2,935 Added 31.62%
12,217 $1.52 Million
Q1 2023

Apr 20, 2023

BUY
$133.98 - $160.47 $94,053 - $112,649
702 Added 8.18%
9,282 $1.36 Million
Q4 2022

Jan 12, 2023

BUY
$129.72 - $159.85 $278,768 - $343,517
2,149 Added 33.42%
8,580 $1.37 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $106,462 - $135,552
841 Added 15.04%
6,431 $857,000
Q2 2022

Jul 19, 2022

BUY
$141.59 - $168.66 $95,006 - $113,170
671 Added 13.64%
5,590 $872,000
Q1 2022

Apr 26, 2022

SELL
$129.64 - $160.7 $26,965 - $33,425
-208 Reduced 4.06%
4,919 $766,000
Q4 2021

Feb 14, 2022

SELL
$119.87 - $145.67 $160,026 - $194,469
-1,335 Reduced 20.66%
5,127 $653,000
Q3 2021

Nov 12, 2021

SELL
$128.64 - $184.79 $29,201 - $41,947
-227 Reduced 3.39%
6,462 $841,000
Q2 2021

Aug 13, 2021

SELL
$160.2 - $186.42 $42,613 - $49,587
-266 Reduced 3.82%
6,689 $1.19 Million
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $1.04 Million - $1.21 Million
6,955 New
6,955 $1.14 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.86B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Hennion & Walsh Asset Management, Inc. Portfolio

Follow Hennion & Walsh Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.